Exact Sciences Is Maintained at Outperform by Evercore ISI Group

Exact Sciences Is Maintained at Outperform by Evercore ISI Group

Dow JonesJul 2 23:32

Evercore ISI Group Maintains Outperform on Exact Sciences, Lowers Price Target to $72

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $80 to $72.

BenzingaJul 2 23:22

Exact Sciences Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 67.42% Evercore ISI Group $80 → $72 Maintains Outperform 06/27/2024 62.77% BTIG $80 → $70 Maint

BenzingaJul 2 23:18

Evercore Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72

Evercore analyst Vijay Kumar maintains $Exact Sciences(EXAS.US)$ with a buy rating, and adjusts the target price from $90 to $72.According to TipRanks data, the analyst has a success rate of 47.4% and

Futu NewsJul 2 20:33 · Ratings

Express News | Geneoscopy: Confident Litigation Will Not Delay Commercial Launch of Colosense

BreakingsJul 1 20:18

Express News | Geneoscopy: Files Counterclaims Against Exact Sciences

BreakingsJul 1 20:17